ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
9.65
-0.54 (-5.30%)
At close: Apr 28, 2026, 4:00 PM EDT
9.72
+0.07 (0.73%)
After-hours: Apr 28, 2026, 5:53 PM EDT
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of $969.46 million as of April 28, 2026. Its market cap has increased by 216.69% in one year.
Market Cap
969.46M
Enterprise Value
695.41M
1-Year Change
216.69%
Ranking
Category
Stock Price
$9.65
Market Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has increased from $741.98M to $969.46M, an increase of 30.66%. That is a compound annual growth rate of 4.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.02B | 28.37% |
| Dec 31, 2025 | 796.64M | 39.89% |
| Dec 31, 2024 | 569.48M | 13.47% |
| Dec 29, 2023 | 501.88M | 89.55% |
| Dec 30, 2022 | 264.77M | -54.26% |
| Dec 31, 2021 | 578.91M | -53.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Septerna | 1.11B |
| Zenas BioPharma | 1.08B |
| Inventiva | 1.06B |
| Xeris Biopharma Holdings | 1.04B |
| KalVista Pharmaceuticals | 1.01B |
| Omeros | 974.11M |
| Geron | 961.35M |
| CytomX Therapeutics | 957.85M |